⋮
0
0
NINLARO® (ixazomib)维持治疗3期试验达到主要终点，显示多发性骨髓瘤移植后患者的无进展生存延长有统计学意义
Showing live article 2047 of 5442 in channel 19680900
Article Details:
Author:
Language: Japanese
Channel Number: 19680900
Article Number: 2047
Date: July 12, 2018, 7:30 pm
URL: http://www.qlifepro.com/press/20180713-20-35405/ma-takeda-pharmaceutical-72/
GUID: http://www.qlifepro.com/press/?p=35405
←
$
..going to article 2047
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
No ratings yet.
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL